Burcu KUMTEPE KURT, Nisa ÇETİN KARGIN, Ezgi DÖNER, Muhammet KIZMAZ

KIRSALDA İLÇE HASTANESİ AİLE HEKİMLİĞİ POLİKLİNİĞİ’NE BAŞVURAN 65 YAŞ ÜSTÜ HASTALARDA POLİFARMASİ PREVELANSI VE ETKİLEYEN FAKTÖRLERİN İNCELENMESİ

Amaç: Bu çalışmanın amacı 65 yaş üstü kadın ve erkek hastalarda polifarmasi prevalansını belirlemek vesosyodemografik özelliklerle ilişkisini araştırmaktır.Materyal ve Metot: Bu çalışma Gemerek Devlet Hastanesi Aile hekimliği polikliniklerine başvuran 65 yaş veüstü hastalarda yüz yüze anket uygulanarak 01.05.2019-01.08.2019 tarihleri arasında yapılan kesitseltanımlayıcı bir araştırmadır. Literatür taraması yapıldıktan sonra araştırmacılar tarafından oluşturulan anketaraştırmacılar tarafından uygulanmıştır.Bulgular: Bu çalışmada yaş ortalaması 71.20±6.60 (min=65 maks=95) olan 358 katılımcı yer almaktadır.Katılımların %55,30’u (n: 198) kadın, %44,70’i erkektir. Polifarmasi prevalansı %38,78 olarak bulunmuştur.Kadınlar arasında polifarmasi sıklığı (%44,42) erkeklere göre (%31,89) istatistiksel olarak anlamlı olarak dahafazla bulunmuştur (p=0,010). En az bir kronik hastalığı olanlarda polifarmasi prevalansı (%53,64) kronikhastalığı olmayanlara (%5,48) göre anlamlı olarak daha fazla bulunmuştur (p

INVESTIGATION OF POLYPHARMACY PREVALENCE AND AFFECTING FACTORS IN PATIENTS OVER 65 YEARS PRESENTING TO FAMILY MEDICINE POLYCLINIC OF RURAL DISTRICT HOSPITAL

Objectives: The aim of this study was to determine the prevalence of polypharmacy in male and female patients over 65 years of age and to investigate its relationship with sociodemographic characteristics. Materials and Methods: This was a cross-sectional descriptive study conducted between 1 May 2019 and 1 August 2019 through a face-to-face interview in patients aged 65 or above who applied to Gemerek State Hospital Family Medicine Clinics. The questionnaire prepared by the researchers following the literature review was applied by researchers. Results: Mean age of this study including 358 individuals (n=198 women (55.3%) and n=160 men (44.70%) was 71.20 ± 6.60 years (range: 65-95). The incidence of polypharmacy was 38.78%. The proportion of women (44.42%) with polypharmacy was higher than that of men (31.89%), it was statistically significant (p

PDF

___

1. Wyles H, Rehman HU. Inappropriate polypharmacy in the elderly. Eur J Intern Med 2005;16(5):311- 3.
2. Veehof L, Stewart R, Haaıjer-Ruskamp F, Meyboom-De Jong, B. The development of polypharmacy: A longitudinal study. Family Practice 2000;17(3):261-7.
3. Zarowıtz BJ, Stebelsky LA, Muma BK, Romaın TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005;25(11):1636-45.
4. Papapetrou I, Jelastopulu E, Symeonıdou E, Klerıdou M, Florıdou D, Charalambous G. Investigation of polypharmacy and rational prescribing in elderly patients in a health centre of Nicosia, Cyprus. China-USA Business Review 2012;11(12):1587-94.
5. Erdinçler DS. Yaşlıda akılcı ilaç kullanımı. İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri 2010; 69: 9-31.
6. Kutsal YG. Yaşlılarda çoklu ilaç kullanımı. Türk Geriatri Dergisi 2006;9:37- 44.
7. Bahat G, Tufan F, Bahat Z ve ark. Comorbidities, polypharmacy, functionality and nutritional status in Turkish community- dwelling female elderly. Aging Clin Exp Res 2014;26(3):255-9.
8. Keine D, Zelek M, Walker JQ, Sabbagh MN. Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms. Neurol Ther 2019;8(1):79-94.
9. Hanlon JT, Linblad CI, Hajjar ER, et al. Update on drug-related problems in the elderly. Am J Geriatr Pharmacother 2003;1(1):38-43.
10. Masodi N. Polypharmacy: To err is human, to correct divine. Br J Clin Pharmacol 2008;1(1):6–9.
11. Fulton MM, Allen ER. Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners 2005;17(4):123-32.
12. Rochon PA, Schmader KE, Sokol HN. [İnternet]. Drug prescribing for older adults. https://www.uptodate.com/contents/drug-prescribing-for-olderadults. (Erişim Tarihi: 30.03.2019).
13. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21(4):294–300.
14. Quinn KJ, Shah NH. A dataset quantifying polypharmacy in the United States. Sci Data 2017;31(4):170167.
15. Nishtala PS, Salahudeen MS. Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9‐year period: 2005‐2013. Gerontology 2015;61(3):195‐202.
16. Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: A retrospective cohort study in the Emilia‐Romagna region, Italy. Drugs Aging 2010;27(12):1019‐28.
17. Nobili A, Franchi C, Pasina L, et al. Drug utilization and polypharmacy in an Italian elderly population: The EPIFARM‐elderly project. Pharmacoepidemiol Drug Saf 2011;20(5):488‐96.
18. Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy among adults aged 65 years and older in the United States: 1988‐2010. J Gerontol A Biol Sci Med Sci 2015;70(8):989‐95.
19. Bor A, Matuz M, Doró P, Viola R, Soós G. Drug‐related problems in the elderly. Orv Hetil 2012;153(49):1926‐36.
20. Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community‐dwelling older adults: A systematic review. J Am Geriatr Soc 2014;62(12):2261‐72.
21. Zelko E, Klemenc‐Ketis Z, Tusek‐Bunc K. Medication adherence in elderly with polypharmacy living at home: A systematic review of existing studies. Mater Sociomed 2016;28(2):129‐32.
22. Carvalho MF, Romano‐Lieber NS, Bergsten‐Mendes G, et al. Polypharmacy among the elderly in the city of São paulo, Brazil ‐ SABE study. Rev Bras Epidemiol 2012;15(4):817‐27.
23. Salih SB, Yousuf M, Durihim H, Almodaimegh H, Tamim H. Prevalence and associated factors of polypharmacy among adult saudi medical outpatients at a tertiary care center. J Family Community Med 2013;20(3):162‐7.
24. Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A. A survey on polypharmacy and use of inappropriate medications. Toxicol Int 2012;19(1):68‐73.
25. Moradi F. Physicians need more pharmaceutical knowledge. Lakartidningen 2014;111:853.